Interventional Cardiology Consultant
Imperial College Healthcare NHS Trust, London, UK
Professor of Cardiology
National Heart and Lung Institute within Imperial College London, UK
Go back to the Executive Board
Professor Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and Professor of Cardiology at the National Heart and Lung Institute within Imperial College London. She is a British Heart Foundation intermediate clinical research fellow and clinical trialist with expertise in stable coronary artery disease, coronary intervention, invasive physiology, and invasive intravascular imaging.
She leads a research group with a focus on clinical trials that impact the care of patients with cardiovascular disease. She believes in rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care.
She designed and led the only placebo-controlled trials of coronary angioplasty, ORBITA and ORBITA-2, published in The Lancet and the New England Journal of Medicine respectively. She was also the chief investigator of the ORBITA-COSMIC trial, published in The Lancet, and ORBITA-STAR, published in JACC. She led The Lancet commission on atherosclerotic heart disease. She is currently leading the ORBITA-FIRE, ORBITA-MOON and ORBITA-SOLAR trials and has over 160 peer-reviewed publications and an h-index of 44. She is actively involved in the development and recruitment for many multi-center international clinical trials.
She is a deputy editor at JACC. She is Deputy Director and head of the second year of Medicine at Imperial College London. She is co-head of the cardiovascular theme of the Imperial NIHR Biomedical Research Centre.